The Effects of Transcutaneous Electrical Nerve Stimulation on People With Knee Osteoarthritis (OA) and or Chronic Pain

N/AUnknownNCT04084236

Omron Healthcare Co., Ltd.30 enrolled

Overview

The purpose of this study is to evaluate the effect of TENS at the knee pain.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Knee Pain

Interventions

electrical stimulationDEVICE

electrical stimulation

ShamDEVICE

no stimulation

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or Female between the ages of 45 years or older * Ultrasonography scale of 0-3 for grading of primary Knee OA of the knee(s) * Pain perceived as a minimum of 3/10 on a 0-10 pain scale with 24 hours of the each visit * No phobia of electrical stimulation * No pain or anti-inflammatory medication will be taken during study * OA and or Chronic knee pain, Injury/pain that began minimum of 6- weeks before the beginning of the study. Exclusion Criteria: * Pregnancy * Diabetes Mellitus * Neuropathy * Smoker * Uncontrolled HTN * Past surgery in the region to be treated by TENS or had received an intra-articular corticosteroid or hyaluronic acid injection within 6 months prior to enrollment * Arthritis (RA) in the area to be treated by TENS * Allergic to tape/electrodes * Dementia * History of knee joint replacement or tibial osteotomy * Undergoing physical therapy * Any major joint pain (e.g., back, hip, or ankle) that could limit functional ability * Contraindications to TENS (pacemakers, dermatological conditions, and abnormal sensation in the knees) * Severe medical or neurological conditions (e.g. Chronic obstructive pulmonary disease, cardiovascular disease, arteriosclerosis obliterans, cerebrovascular accident, lumber disc, herniation, and rheumatoid arthritis) * The subject does not utilize stairs in daily living * The subject is unable to walk without ambulatory assistive devices.

Locations (1)

Omron healthcare Co.,Ltd.

Mukō, Japan

RECRUITING

Outcomes

Primary Outcomes

stair climb test

An 11-step stairway with a step height of 17 cm will be used. Participants will begin with both feet on the bottom landing, then ascend and descend the stairway as fast as possible, and finally stop with both feet back on the bottom landing while using a handrail support, if required. Time recording will be started when the participant is signalled to start and ended when the participant returns with both feet on the ground.

Time frame: 2 hours

timed Up and Go test (TUG)

The participant will sit down at first and then stand up when given the signal to start. As fast as possible, the participant will walk 3 meters toward a cone on the floor, circle it, walk back 3 more meters toward a chair, and finally sat down. Timing begins on the signal to start and ends when the participant completely sits down with their back resting on the backrest of the chair.

Time frame: 2 hours

6-minute walk test (6MWT)

In the 6MWT, the participants will walk as far as they could within 6 minutes. They will not be allowed to carry a watch or provided feedback during the trial. Although rest periods are allowed, time recording will continue. The participants will be provided encouragement at 1-minute intervals.

Time frame: 2 hours

VAS(Visual Analog Scale score) for knee pain

The mean knee pain during the stair climb test, TUG test, and 6MWT will be measured using the VAS. Participants will record their level of knee pain by drawing a vertical mark between the ends of a 10-cm horizontal line. The 0-cm end and the 10-cm end represented no pain and the most extreme pain, respectively.

Time frame: 2 hours

The Knee injury and Osteoarthritis Outcome Score (KOOS)

The Knee injury and Osteoarthritis Outcome Score (KOOS) was developed as an extension of the WOMAC Osteoarthritis Index with the purpose of evaluating short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis. The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Secondary Outcomes

2-step test

Gait stride length is measured to assess walking ability, including muscle strength, balance, and flexibility of the lower limbs. The starting line is determined, and participants stand with the toes of both feet behind this line. They take 2 long steps (as long as possible) and then align both their feet. Subsequently, the length of the 2 steps from the starting line to the toes is measured.

Time frame: 2 hours

stand-up test

The participant will stand up on 1 or both legs from a seat at a specified height. For this test, 4 seats are set up at different heights (40, 30, 20, and 10 cm). First, the participants will sit on the 40-cm high seat with arms folded. If they can stand up on both legs, they then attempt to stand on 1 leg. If they can stand up on both their right and left legs, they pass the height level. The participants then repeat the trial at the next seat height, and the trials will be performed in the order of descending height.

Time frame: 2 hours

Knee extensor strength

The maximum isometric knee extensor strengths will be measured using a handheld dynamometer (HHD), which is the validated method in a previous research on elderly individuals who are prone to falls.17 The maximum force will be recorded in Newtons (N), and testing will be repeated for 2 measurements.

Time frame: 2 hours